KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Liabilities and Shareholders Equity (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Liabilities and Shareholders Equity readings, the most recent being $113.3 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 14.38% to $113.3 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $427.9 billion, a 8.26% increase, with the full-year FY2025 number at $110.3 billion, up 13.38% from a year prior.
  • Liabilities and Shareholders Equity hit $113.3 billion in Q1 2026 for Thermo Fisher Scientific, up from $110.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $113.3 billion in Q1 2026 to a low of $90.5 billion in Q4 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $97.3 billion (2024), compared with a mean of $98.6 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 40.67% in 2022 and later decreased 1.42% in 2024.
  • Thermo Fisher Scientific's Liabilities and Shareholders Equity stood at $97.2 billion in 2022, then grew by 1.62% to $98.7 billion in 2023, then dropped by 1.42% to $97.3 billion in 2024, then increased by 13.38% to $110.3 billion in 2025, then increased by 2.66% to $113.3 billion in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $113.3 billion (Q1 2026), $110.3 billion (Q4 2025), and $103.0 billion (Q3 2025) per Business Quant data.